Alcohol-based cirrhosis on rise in Britain

Mar 19, 2007

Cases involving cirrhosis of the liver by alcohol among British people aged 25-to-34 years have more than doubled during the last decade, figures show.

The Times of London said that recent information presented to Britain's Liberal Democrats showed that between 1996-97 and 2005-06, the number of alcohol-related cirrhosis instances rose from 270 to 642.

During that same time period, the amount of overall cirrhosis cases rose from nearly 7,000 annually to more than 19,000 a year.

Royal College of Physicians President Ian Gilmore said that recent medical findings of increased final-stage cirrhosis in the age group suggest that the negative pattern is likely to rise further in the future.

Such findings prompted Sandra Gidley, the Liberal Democrat health spokeswoman, to criticize the current British healthcare system.

"Ministers should have woken up to this issue and taken action years ago," she told the paper.

Copyright 2007 by United Press International

Explore further: Amgen misses 1Q views as higher costs cut profit

add to favorites email to friend print save as pdf

Related Stories

Racial stereotyping found in US death certificates

Jan 26, 2011

Death by homicide, the victim is probably black. By cirrhosis, the decedent is likely Native American. These stereotypes have small but clear effects on the racial classifications used to calculate official vital statistics, ...

Colo. scrub tech hears charges in hepatitis C case

Jul 07, 2009

(AP) -- A Denver hospital said Monday it has asked every patient who had surgery there over a six-month period to come in for a blood test amid allegations that a former technician exposed up to 6,000 people to hepatitis ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

21 hours ago

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Cyber buddy is better than 'no buddy'

A Michigan State University researcher is looking to give exercise enthusiasts the extra nudge they need during a workout, and her latest research shows that a cyber buddy can help.